Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Neuromodulation for metabolic conditions or syndromes

Neuromodulation for metabolic conditions or syndromes

US Patent 10856926 · Granted Dec 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl amide inhibitors of CD382025
Method of eradicating ticks that attach to humans using lotilaner formulations2025
Isoxazoline parasiticide formulations2025
Isoxazoline parasiticide formulations2025
Isoxazoline parasiticide formulations and methods for treating blepharitis2024
Neuromodulation for metabolic conditions or syndromes2024
Neuromodulation for metabolic conditions or syndromes2024
Neuromodulation for metabolic conditions or syndromes2024
Modulation of targeted nerve fibers2024
Modulation of targeted nerve fibers2024
Modulation of targeted nerve fibers2024
Ophthalmic compositions for treating ocular Demodex using lotilaner formulations2023